Are you a recent graduate, career changer, or new immigrant to North America looking to build a high-paying career in enterprise technology? SAPSOL Technologies Inc. is actively sourcing and onboarding Entry-Level SAP Consultants for our upcoming enterprise
About Forma.ai: Forma.ai is a Series B startup thats revolutionizing how sales compensation is designed, managed and optimized. We handle billions in annual managed commissions for market leaders like Edmentum, Stryker, and Autodesk. Our growth has
Clorox is the place that’s committed to growth – for our people and our brands. Guided by our purpose and values, and with people at the center of everything we do, we believe every one of
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead Maestro, an AI-native inventory-planning intelligence venture. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. Maestro is an autopilot planning
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead Crossfoot, an AI-native accounting agent platform. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. Crossfoot is agentic accounting for
The Opportunity FutureSight is seeking an experienced, visionary entrepreneur to co-found its next B2B AI venture with us. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. This opportunity is open
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead Weli AI, a B2B WealthTech venture. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. Weli AI is an embedded
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead Concordance, an AI-native clinical documentation compliance venture. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. Concordance AI audits 100%
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead HawkAI, an enterprise AI venture for US logistics brokerages, carriers, and warehouse operators. This is a co-founder partnership with meaningful founder equity, not a salaried
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead InfluTracker, an AI-native content intelligence and publishing venture. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. InfluTracker is an
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead Foundry, an AI-Native Recruiting Agency currently in build at FutureSight. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. Recruiting
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead Omnex, an AI-native operating system for multi-channel ecommerce sellers, currently in build at our studio. This is a co-founder partnership with meaningful founder equity, not
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead Reclaim, an AI-native denial management and revenue recovery venture. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. We are
The Opportunity FutureSight is seeking a Co-Founder & CEO to lead LucentAI, an AI-native litigation operations venture in build at FutureSight. This offers meaningful founder equity, not a salary. LucentAI serves as an autopilot for medical-records
Have you heard of BlueCat? We’re one of those hidden gems disrupting the market as a key player in the rapidly growing space of Intelligent Network Operations. Organizations require a new model of network operations—one that
Who We Are: Clearsulting is a global consulting company with the motivation to deliver positive change through digital finance. Our team consists of finance specialists that bring experience and technical capabilities across the spectrum of finance,
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our